Johanna Englundh

Saab stock is down 24% in three months, but growing defense budgets could create long-term upside, Morningstar’s analyst says.

Global equity funds are dominated by US stocks, but European markets come with their own concentration risks.

European and US stock markets weakened amid rising tensions over trade and geopolitics while the US dollar lost ground.

Denmark leads Nordic losses amid rising US tariff concerns.

Novo Nordisk falls while other European drugmakers hold firm as markets assess limited fallout.

Slide in Novo Nordisk and Orsted shares make Denmark one of the worst-performing stock markets in the world this year.

These stocks from Northern Europe offer AI exposure beyond the US tech giants, and some are trading below fair value.

Danish pharma giant Novo Nordisk faces tough competition from its main US rival and cheaper copycat obesity drugs.

Alternative energy and clean energy funds and ETFs are amongst the hardest hit after the Danish wind energy stock’s slide.

Israeli airstrikes on Iran rattled markets on Friday as Middle East tensions are set to escalate.

Novo Nordisk has shed more than 50% of its valuation since the peak in June 2024.

Your market downturn and volatility questions, answered.

These Nordic stocks give you exposure to some of the world’s leading companies.

Shares of the pharmaceutical giant plummeted 20% after a late-stage weight loss drug trial missed expectations.

The EU had high hopes for hydrogen in the clean energy transition, but it’s still expensive and demand is low.

The sector faces plenty of challenges such as possible US trade tariffs, but these six stocks are screening as undervalued.

Dollar, American equities and bitcoin gain as Republican presidential candidate secures a decisive win.

Norges Bank dealing with higher inflation than in eurozone and Sweden

These 10 stocks are common picks amongst the top-rated EM funds available to European investors

When the door opens to retail investors, private equity firms could face greater regulatory scrutiny impacting the high fees seen historically

Video: Morningstar senior equity analyst Matthew Donen highlights the ongoing challenges for wind energy companies, but also emphasises the positive outlook 

Shares of pharmaceutical giant slide after presenting a weaker-than-expected net profit while trimming its operating profit outlook. 

VIDEO: As NATO leaders begin their anniversary conference in Washington D.C., Loredana Muharremi explains what lies behind the recent correction in the defence sector

VIDEO: Morningstar Sustainalytics Ruby Jeng explains that companies can manage their material ESG risks

The sector faces plenty of challenges but a number of stocks are screening as undervalued

Morningstar has raised the fair value estimate for the Danish pharma stock, but shares are still overvalued

VIDEO: Morningstar equity analyst Loredana Muharremi explains why she allocated the defence stock a wide moat rating and the reasons behind the fair value estimate

Negative market reaction follows warning about shipping oversupply, suspension of share buybacks, but Morningstar thinks the stock is still undervalued

Return to profit, higher prices and forecast-beating order book impressed investors in the Danish wind turbine maker, even with high expectations

Investors will be watching keenly for an outlook on Red Sea turbulence when the shipping giant reports earnings on Thursday